Christer Mller - BioArctic VP Officer

BIOA-B Stock

SEK 194.40 5.30 2.80%

Insider

Christer Mller is VP Officer of BioArctic AB

Age	64
Phone	46 86 95 69 30
Web	https://www.bioarctic.se

BioArctic Management Efficiency

BioArctic's management efficiency ratios could be used to measure how well BioArctic manages its routine affairs as well as how well it operates its assets and liabilities.

Compare BioArctic to Peers

Predict price of BioArctic

BioArctic AB has accumulated 7.79 M in total debt with debt to equity ratio (D/E) of 3.0, implying the company greatly relies on financing operations through barrowing. BioArctic AB has a current ratio of 5.51, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist BioArctic until it has trouble settling it off, either with new capital or with free cash flow. So, BioArctic's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioArctic AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioArctic to invest in growth at high rates of return. When we think about BioArctic's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives			INSIDER Age
	Annika MBA	Oncopeptides AB	57
	Thoas MD	Cantargia AB	61
	MSc MD	Oncopeptides AB	N/A
	Peter Hjelmstrom	Camurus AB	50
	Marcuss	Cantargia AB	N/A
	Emanuel Bjrne	Hansa Biopharma AB	50
	Rein BSc	Camurus AB	65
	Jon Alonso	Camurus AB	50
	Johanna Christensen	Cantargia AB	N/A
	Kristina Luthman	Oncopeptides AB	N/A
	Annette Mattsson	Camurus AB	57
	Maria Lundqvist	Camurus AB	57
	Adnan Deronic	Cantargia AB	N/A
	Peter Madsen	Cantargia AB	N/A
	Pr MD	Oncopeptides AB	N/A
	Susanne Lagerlund	Cantargia AB	N/A
	Nina Valkama	Cantargia AB	N/A
	Dominique Tersago	Cantargia AB	61
	Katja Margell	Hansa Biopharma AB	N/A
	Kjell Sjstrm	Cantargia AB	N/A
	Peter Nygren	Oncopeptides AB	64

BioArctic AB , a research intensive biopharmaceutical company, develops disease modifying treatments and diagnostics for neurodegenerative diseases in Sweden. BioArctic AB was founded in 1992 and is headquartered in Stockholm, Sweden. BioArctic is traded on Stockholm Stock Exchange in Sweden. BioArctic AB (BIOA-B) is traded on Stockholm Exchange in Sweden and employs 61 people.

Management Performance

	Return On Equity	-0.0142
	Return On Asset	-0.0055

BioArctic AB Leadership Team

Elected by the shareholders, the BioArctic's board of directors comprises two types of representatives: BioArctic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioArctic. The board's role is to monitor BioArctic's management team and ensure that shareholders' interests are well served. BioArctic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioArctic's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Gunilla Andersson, Director HR
	Pr Gellerfors, Sr CoFounder
	Jan Mattsson, S Fin
	Christer Mller, VP Officer
	Gunilla Osswald, Chief Officer
	Pr Lannfelt, VP CoFounder
	Oskar Bosson, VP IR
	Frida Lekander, Head Marketing
	Johanna Flting, VP Research
	Harald Borgeke, Head Affairs

BioArctic Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioArctic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

	Return On Equity	-0.0142
	Return On Asset	-0.0055
	Profit Margin	(0.05) %
	Operating Margin	(0.03) %
	Current Valuation	26.19 B
	Shares Outstanding	73.73 M
	Shares Owned By Insiders	48.40 %
	Shares Owned By Institutions	30.39 %
	Price To Earning	12.95 X
	Price To Book	32.29 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Other Information on Investing in BioArctic Stock

BioArctic financial ratios help investors to determine whether BioArctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioArctic with respect to the benefits of owning BioArctic security.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC